Evolocumab — Nutrient Associations & Health Patterns
Also known as: Evolocumab (Repatha)
Drug Class: PCSK9 inhibitor
Monoclonal antibody that inhibits PCSK9, dramatically lowering LDL cholesterol. Administered by injection, typically used for familial hypercholesterolemia or high-risk cardiovascular patients. Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
Medication and Nutrition Context
Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
Common Side Effects of Evolocumab
- Injection site reactions
- Upper respiratory infections
- Flu-like symptoms
- Muscle pain
- Fatigue
- Back pain
Key Drug Interactions — Evolocumab
Evolocumab has 2 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Statins (often used together)
- Other lipid-lowering therapies
Frequently Asked Questions
What nutrient associations are reported for Evolocumab?
Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
Which nutrient relationships are mapped for Evolocumab?
Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
What are the side effects of Evolocumab?
Common side effects associated with Evolocumab include: Injection site reactions; Upper respiratory infections; Flu-like symptoms; Muscle pain; Fatigue.